Prostate and Urinary Cancers

Overview Patient selection for internal radioligand therapy (RLT) with [177Lu]Lu-PSMA is challenging, with still a lot of open questions. Patients with intense PSMA-uptake on a PET/CT scan tend to respond better compared to patients with low to moderate accumulation in the tumor. However, an ideal cut off for patient selection is still discussed controversially. In

Overview The aim of the presentation entitled “Hormone-Sensitive Prostate Cancer” is tooffer the audience an overview of already finalized, ongoing and future trials regarding PSMA RLT trials in Prostate cancer. Therefore , the content of the lesson will comprise a detailed overview of some relevant trials with published results, namely the DOSTOX, a prospective pilot